Erica Andersen

Erica Andersen

Auto-generated profile, based on publicly available information

Erica Andersen

ARUP Laboratories, Cytogenetics and Genomic Microarray, Salt Lake City, USA

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2017 in Laboratory Investigation
Verified
Journal Article
Open access
PDF file
CPChristian N Paxton
Christian N Paxton
DODennis P O'Malley
Dennis P O'Malley
ABAndrew M Bellizzi
Andrew M Bellizzi
DADeema Alkapalan
Deema Alkapalan
YFYuri Fedoriw
Yuri Fedoriw
EAErica F Andersen
Erica F Andersen
Juvenile xanthogranuloma is a rare histiocytic proliferation primarily affecting infants and young children, characterized by aberrant infiltration of histiocyte-derived cells in the skin, soft tissues and more rarely, visceral organs. Juvenile xanthogranuloma is generally considered to be a benign disorder; most lesions are solitary cutaneous nodules that resolve spontaneously without treatment. However, cases with extracutaneous involvement, multiple lesions, and/or systemic disease often require aggressive therapy. Though molecular studies have provided evidence of clonality in juvenile xanthogranuloma, in support of a neoplastic process, little is known about the genetic profile of juvenile xanthogranuloma. We used molecular inversion probe array technology to evaluate the genomic characteristics (copy number alterations or copy neutral-loss of heterozygosity) of 21 archived cases of juvenile xanthogranuloma (19 solitary, 1 diffuse cutaneous, 1 systemic). Four cases (19%) showed acquired, clonal alterations. Two lesions from a case of diffuse cutaneous juvenile xanthogranuloma showed distinct profiles: JXG-1a contained trisomy 5 and 17 and JXG-1b contained loss of heterozygosity in 5q. The systemic juvenile xanthogranuloma (JXG-2) showed multiple genomic alterations. Only two of 19 solitary juvenile xanthogranulomas showed abnormal genomic profiles: JXG-3 showed gains on 1q and 11q and JXG-4 showed a 7.2 Mb loss in 3p. No recurrent abnormalities were observed among these cases. The presence of non-recurrent copy number alterations in a subset of samples implies that copy number changes are unlikely driving pathogenesis in juvenile xanthogranuloma, but may be acquired during disease progression. The presence of genomic abnormalities in more advanced cases (ie, systemic and diffuse cutaneous juvenile xanthogranuloma) supports this notion, particularly as the advanced cases of juvenile xanthogranuloma presented more genomic complexity.

24 October 2024 in European Journal of Human Genetics
Verified
Journal Article
Open access
PDF file
Angela PeronAngela Peron
Angela Peron
FDFelice D’arco
Felice D’arco
KAKimberly A. Aldinger
Kimberly A. Aldinger
CSConstance Smith-Hicks
Constance Smith-Hicks
CZChristiane Zweier
Christiane Zweier
T(Telethon Undiagnosed Disease Program (Tudp)
Telethon Undiagnosed Disease Program (Tudp)
An increasing number of individuals with intellectual developmental disorder (IDD) and heterozygous variants in BCL11A are identified, yet our knowledge of manifestations and mutational spectrum is lacking. To address this, we performed detailed analysis of 42 individuals with BCL11A-related IDD (BCL11A-IDD, a.k.a. Dias-Logan syndrome) ascertained through an international collaborative network, and reviewed 35 additional previously reported patients. Analysis of 77 affected individuals identified 60 unique disease-causing variants (30 frameshift, 7 missense, 6 splice-site, 17 stop-gain) and 8 unique BCL11A microdeletions. We define the most prevalent features of BCL11A-IDD: IDD, postnatal-onset microcephaly, hypotonia, behavioral abnormalities, autism spectrum disorder, and persistence of fetal hemoglobin (HbF), and identify autonomic dysregulation as new feature. BCL11A-IDD is distinguished from 2p16 microdeletion syndrome, which has a higher incidence of congenital anomalies. Our results underscore BCL11A as an important transcription factor in human hindbrain development, identifying a previously underrecognized phenotype of a small brainstem with a reduced pons/medulla ratio. Genotype-phenotype correlation revealed an isoform-dependent trend in severity of truncating variants: those affecting all isoforms are associated with higher frequency of hypotonia, and those affecting the long (BCL11A-L) and extra-long (-XL) isoforms, sparing the short (-S), are associated with higher frequency of postnatal microcephaly. With the largest international cohort to date, this study highlights persistence of fetal hemoglobin as a consistent biomarker and hindbrain abnormalities as a common feature. It contributes significantly to our understanding of BCL11A-IDD through an extensive unbiased multi-center assessment, providing valuable insights for diagnosis, management and counselling, and into BCL11A’s role in brain development.

1 April 2021 in Molecular Genetics and Metabolism
Verified
Journal Article
Closed access
ERErin Riggs
Erin Riggs
MGMolly Good
Molly Good
EAErica Andersen
Erica Andersen
SKSibel Kantarci
Sibel Kantarci
HKHutton Kearney
Hutton Kearney
CMChrista Martin
Christa Martin

1 April 2021 in Molecular Genetics and Metabolism
Verified
Journal Article
Closed access
NANajla Al-Sweel
Najla Al-Sweel
EDElzbieta Drozd-Borysiuk
Elzbieta Drozd-Borysiuk
GBGeorge Bonnet
George Bonnet
EAErica Andersen
Erica Andersen
RTReha Toydemir
Reha Toydemir
BHBo Young Hong
Bo Young Hong

1 April 2021 in Molecular Genetics and Metabolism
Verified
Journal Article
Closed access
MGMolly Good
Molly Good
EAErica Andersen
Erica Andersen
ACAdam Clayton
Adam Clayton
JZJian Zhao
Jian Zhao
CMChrista Martin
Christa Martin
ERErin Riggs
Erin Riggs

1 April 2021 in Molecular Genetics and Metabolism
Verified
Journal Article
Closed access
JHJohn Herriges
John Herriges
EAErica Andersen
Erica Andersen
BCBradley Coe
Bradley Coe
LCLaura Conlin
Laura Conlin
BHBenjamin Hilton
Benjamin Hilton
CMChrista Martin
Christa Martin